135 related articles for article (PubMed ID: 20738267)
1. Successful isolated liver transplantation in a child with atypical hemolytic uremic syndrome and a mutation in complement factor H.
Haller W; Milford DV; Goodship TH; Sharif K; Mirza DF; McKiernan PJ
Am J Transplant; 2010 Sep; 10(9):2142-7. PubMed ID: 20738267
[TBL] [Abstract][Full Text] [Related]
2. Successful simultaneous liver-kidney transplant in an adult with atypical hemolytic uremic syndrome associated with a mutation in complement factor H.
Wilson C; Torpey N; Jaques B; Strain L; Talbot D; Manas D; Goodship T
Am J Kidney Dis; 2011 Jul; 58(1):109-12. PubMed ID: 21601332
[TBL] [Abstract][Full Text] [Related]
3. Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.
Saland JM; Shneider BL; Bromberg JS; Shi PA; Ward SC; Magid MS; Benchimol C; Seikaly MG; Emre SH; Bresin E; Remuzzi G
Clin J Am Soc Nephrol; 2009 Jan; 4(1):201-6. PubMed ID: 19005013
[TBL] [Abstract][Full Text] [Related]
4. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
Tran H; Chaudhuri A; Concepcion W; Grimm PC
Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
[TBL] [Abstract][Full Text] [Related]
5. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
[TBL] [Abstract][Full Text] [Related]
6. Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H.
Jalanko H; Peltonen S; Koskinen A; Puntila J; Isoniemi H; Holmberg C; Pinomäki A; Armstrong E; Koivusalo A; Tukiainen E; Mäkisalo H; Saland J; Remuzzi G; de Cordoba S; Lassila R; Meri S; Jokiranta TS
Am J Transplant; 2008 Jan; 8(1):216-21. PubMed ID: 17973958
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome.
Weitz M; Amon O; Bassler D; Koenigsrainer A; Nadalin S
Pediatr Nephrol; 2011 Aug; 26(8):1325-9. PubMed ID: 21556717
[TBL] [Abstract][Full Text] [Related]
8. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option?
Hirt-Minkowski P; Schaub S; Mayr M; Schifferli JA; Dickenmann M; Frémeaux-Bacchi V; Steiger J
Nephrol Dial Transplant; 2009 Nov; 24(11):3548-51. PubMed ID: 19633317
[TBL] [Abstract][Full Text] [Related]
9. Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation.
Kim S; Park E; Min SI; Yi NJ; Ha J; Ha IS; Cheong HI; Kang HG
J Korean Med Sci; 2018 Jan; 33(1):e4. PubMed ID: 29215813
[TBL] [Abstract][Full Text] [Related]
10. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
[TBL] [Abstract][Full Text] [Related]
11. Favorable long-term outcomes of isolated liver transplantation in a child with atypical hemolytic uremic syndrome caused by a novel complement factor H mutation
.
Cho H; Lee Y
Clin Nephrol; 2017 Jul; 88(1):52-56. PubMed ID: 28502324
[TBL] [Abstract][Full Text] [Related]
12. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
Davin JC; Gracchi V; Bouts A; Groothoff J; Strain L; Goodship T
Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549
[TBL] [Abstract][Full Text] [Related]
14. Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations.
Kim JJ; Goodship TH; Tizard J; Inward C
Pediatr Nephrol; 2011 Nov; 26(11):2073-6. PubMed ID: 21717289
[TBL] [Abstract][Full Text] [Related]
15. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
[TBL] [Abstract][Full Text] [Related]
16. Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.
Krid S; Roumenina LT; Beury D; Charbit M; Boyer O; Frémeaux-Bacchi V; Niaudet P
Am J Transplant; 2012 Jul; 12(7):1938-44. PubMed ID: 22494769
[TBL] [Abstract][Full Text] [Related]
17. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP.
Cruzado JM; de Córdoba SR; Melilli E; Bestard O; Rama I; Sánchez-Corral P; López-Trascasa M; Navarro I; Torras J; Gomà M; Grinyó JM
Am J Transplant; 2009 Jun; 9(6):1477-83. PubMed ID: 19459807
[TBL] [Abstract][Full Text] [Related]
18. Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations.
Pabst WL; Neuhaus TJ; Nef S; Bresin E; Zingg-Schenk A; Spartà G
Pediatr Nephrol; 2013 Jul; 28(7):1141-4. PubMed ID: 23519521
[TBL] [Abstract][Full Text] [Related]
19. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
Bresin E; Rurali E; Caprioli J; Sanchez-Corral P; Fremeaux-Bacchi V; Rodriguez de Cordoba S; Pinto S; Goodship TH; Alberti M; Ribes D; Valoti E; Remuzzi G; Noris M;
J Am Soc Nephrol; 2013 Feb; 24(3):475-86. PubMed ID: 23431077
[TBL] [Abstract][Full Text] [Related]
20. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
Vondrák K; Seeman T
Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
